In summary, we have shown that the treatment of HTC-IR hepatoma cells with the selective COX-2 inhibitor, celecoxib, was associated with induction of apoptosis and complete inhibition of cell proliferation, suppression of ODC activity, and diminished c-fos expression. Here, FOS is linked to hepatocellular carcinoma.